Kathrin Ladetzki-Baehs

USPTO Granted Patents = 9 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 149(Granted Patents)

Company Filing History:

Years Active: 2012-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410255 - Natriuretic peptide receptor 1 antibodies and methods of use (2025-09-09),

2. 12344659 - Canine antibody libraries (2025-07-01),

3. 11702463 - Canine antibody libraries (2023-07-18),

4. 11066469 - Natriuretic peptide receptor 1 antibodies and methods of use (2021-07-20),

5. 11014978 - Canine antibody libraries (2021-05-25),

6. 10640568 - 4-1BB binding molecules (2020-05-05),

7. 9468678 - Method of producing 4-1BB binding molecules and associated nucleic acids (2016-10-18),

8. 8821867 - 4-1BB binding molecules (2014-09-02),

9. 8337850 - 4-1BB binding molecules (2012-12-25),

Title: Kathrin Ladetzki-Baehs: Innovator in Antibody Research

Introduction

Kathrin Ladetzki-Baehs is a prominent inventor based in Planegg, Germany. She has made significant contributions to the field of antibody research, holding a total of 9 patents. Her work focuses on innovative methods and compositions that have the potential to impact medical treatments.

Latest Patents

Among her latest patents is the development of Natriuretic peptide receptor 1 antibodies and methods of use. This disclosure relates to anti-Natriuretic Peptide Receptor 1 (NPR1) antibodies, including agonist antibodies that can activate the NPR1 receptor. The patent also covers pharmaceutical compositions comprising these antibodies and methods of treatment utilizing them. Another notable patent involves the creation of synthetic canine antibody libraries, which includes polypeptides, nucleic acids, vectors, host cells, and methods used in conjunction with these libraries. This invention also provides antibodies isolated from such libraries.

Career Highlights

Kathrin has worked with leading companies in the pharmaceutical industry, including Pfizer Corporation and MorphoSys AG. Her experience in these organizations has allowed her to develop and refine her expertise in antibody research and innovation.

Collaborations

Kathrin has collaborated with notable professionals in her field, including Bianca Ahrens and Sangita M Baxi. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Kathrin Ladetzki-Baehs is a distinguished inventor whose work in antibody research continues to pave the way for new medical treatments. Her innovative patents and collaborations highlight her significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.